Results 31 to 39 of about 40 (39)

Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK -positive non–small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteria

European Journal of Cancer, 2017
Leena Gandhi, Sai-Hong Ignatius Ou, Fabrice Barlesi   +2 more
exaly  

Updated Response Assessment in Neuro-Oncology (RANO) for Gliomas

Current Neurology and Neuroscience Reports
Youssef Gilbert
exaly  

Response Assessment in Neuro-Oncology (RANO) 2009–2025: Broad scope and implementation—A progress report

Neuro-Oncology
, Timothy F Cloughesy, Norbert Galldiks
exaly  

Standardized MRI assessment of high-grade glioma response: a review of the essential elements and pitfalls of the RANO criteria

Neuro-Oncology Practice, 2016
exaly  

Prognostic revalidation of RANO categories for extent of resection in glioblastoma: a reconstruction of individual patient data

Journal of Neuro-Oncology
Martin Vychopen, Erdem Güresir, Wach Johannes   +2 more
exaly  

Development and routine implementation of deep learning algorithm for automatic brain metastases segmentation on MRI for RANO-BM criteria follow-up

NeuroImage
Dinu Stefan, Alexis Lechervy, Aurélien Corroyer-Dulmont   +2 more
exaly  

Supramaximal resection: retrospective study on IDH-wildtype Glioblastomas based on the new RANO-Resect classification

Acta Neurochirurgica
Luca Raspagliesi, Federico Pessina, Tropeano Maria Pia   +2 more
exaly  

The use of minor response, volumetric assessment, and growth rate kinetics as endpoints in grade 1-3 glioma clinical trials: a RANO perspective

Neuro-Oncology
, Timothy F Cloughesy, Benjamin M Ellingson   +2 more
exaly  

PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group

Lancet Oncology, The
exaly